Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar

OBJECTIVES: To evaluate an intervention to reduce the nocebo effect (NE) when switching from the originator infliximab (OI) to the infliximab biosimilar SB2 in chronic inflammatory rheumatic disease (CIRD). METHODS: An intervention was built with healthcare professionals (HPs) and a patient represen...

Descripción completa

Detalles Bibliográficos
Autores principales: Petit, Juliette, Antignac, Marie, Poilverd, Rose-Marie, Baratto, Régine, Darthout, Sylvie, Desouches, Sandra, Louati, Karine, Deparis, Nathalie, Berenbaum, Francis, Beauvais, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Education
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839879/
https://www.ncbi.nlm.nih.gov/pubmed/33495387
http://dx.doi.org/10.1136/rmdopen-2020-001396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839879/
https://www.ncbi.nlm.nih.gov/pubmed/33495387
http://dx.doi.org/10.1136/rmdopen-2020-001396

Ejemplares similares